REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/01/2025
Back to search
Official data from USPTO
ADVITOS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ADVITOS
ST13
US500000079255067Class
5, 9, 10, 35, 41, 42, 44
Filing
79255067
Registration
6138384
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
09/02/2025
Trademark type
Word
Nice classes
5, 9, 10, 35, 41, 42, 44
Filing date
10/24/2018
Registration date
09/01/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/01/2020
Last transaction
09/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
DE
Examiner
COLLOPY, DIANE
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ADVITOS GmbH
Hepa Wash GmbH
Representatives
Hepa Wash GmbH
Technical classification
Nice Classes
Class 5Class 9Class 10Class 35Class 41Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals for the treatment of liver failurerenal failure and multiple organ failure; sanitary preparations for medical purposes; pharmaceutical solutions for the treatment of liver failurerenal failure and multiple organ failure; diagnostic preparations for medical purposes; biological indicators for monitoring of detoxification parameters for medical purposes; dialysate; pharmaceutical solutions used in dialysis; antiseptics with therapeutic effect; radio-isotope markers for therapeutic or diagnostic use; clinical medical reagents; antibiotics for detoxification purposes; diuretics for detoxification purposes; blood cleaners for detoxification purposes; laxatives for detoxification purposes
Class 9
Apparatus and instruments for conductingswitchingtransformingaccumulatingregulating or controlling electricity; apparatus for recordingtransmission or reproduction of sound or images; magnetic data mediafloppy disks offered pre-recorded with information on a method for the combined multi-organ support of liverlungkidneyacid-base balance; phonograph records offered pre-recorded with information on a method for the combined multi-organ support of liverlungkidneyacid-base balance; compact discs offered pre-recorded with information on a method for the combined multi-organ support of liverlungkidneyacid-base balance; DVDs offered pre-recorded with information on a method for the combined multi-organ support of liverlungkidneyacid-base balance; digital recording mediausb drives offered pre-recorded with information on a method for the combined multi-organ support of liverlungkidneyacid-base balance; computers; Downloadable computer software for operating medical devices used in patients under treatment with a method for combined multi-organ support of liverlungkidneyacid-base balance; data processing apparatus and computers; diagnostic apparatusnot for medical purposesdiagnostic apparatus for the detection of pathogens for laboratory or research use; electronic apparatus for testing the sterility of pharmaceuticals and injectable solutions; Downloadable virtual reality software for remote user support assistance and training enabling physicians and nurses to perform medical procedures for the treatment of liver failurerenal failurelung failure and/or multiple organ failure
Class 10
Orthopedic articlesorthopedic beltscushions and paddingfootwear and inserts for footwearknee bandagesshoessoleswalkers; apparatus and instruments for extracorporeal blood cleansing processes; devices for extracorporeal blood cleansing processes; dialyzers; diagnostic apparatus for measuring and monitoring patients' vital physiological and chemical parameters within the treatment of liver failurerenal failurelung failureand/or multiple organ failure
Class 35
Wholesale and retail store services featuring apparatus and instruments for the treatment of liver failurerenal failure and multiple organ failure as well as apparatus and instruments for conductingswitchingtransformingaccumulatingregulating or controlling electricityapparatus for recordingtransmission or reproduction of sound or images
Class 41
Education servicesproviding tutoring in the field of the treatment of liver failurerenal failure and multiple organ failure; providing of training in the field of the treatment of liver failurerenal failure and multiple organ failure; organizing community sporting and cultural eventslive musical performancesculinary events and arts events; Education servicesproviding tutoring and training in the field of pharmacology; Education servicesproviding classes in the therapeutic treatment of liver failurerenal failure and multiple organ failure; training services for nurses in the field of the treatment of liver failurerenal failure and multiple organ failure; conducting educational support programmes for patients in the field of the treatment of liver failurerenal failure and multiple organ failure
Class 42
Scientific and technological design and development services of medical devices and software applicationsall in the field of the treatment of liver failurerenal failurelung failureand/or multiple organ failure; design and development of computer hardware and software; medical laboratory services; medical and pharmacological research services; inspection of pharmaceuticals; consultancy relating to pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields; pharmaceutical product evaluation; consultancy relating to research and development in the field of pharmaceutical therapeutics; biological research; clinical research in the field of the treatment of liver failurerenal failure and multiple organ failure; medical research; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; design and development of medical diagnostic apparatus; electronic storage of medical records
Class 44
Medical services; hygienic and beauty care for human beings or animals; hospital services; medical assistance; pharmaceutical consultancy services; medical servicestherapeutic treatment of the body; nursing home services; medical clinic services; medical treatment services provided by clinics and hospitals; medical diagnostic services; medical testing for diagnostic or treatment purposes; medical servicesmonitoring of patients
Publications
History of USPTO decisions and trademark events.
40 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/09/2021
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/25/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/18/2020
FIMP
FINAL DISPOSITION PROCESSED
12/18/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/01/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
10/27/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
09/01/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/26/2020
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
08/25/2020
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
08/25/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/16/2020
PUBO
PUBLISHED FOR OPPOSITION
06/16/2020
GPNX
NOTIFICATION PROCESSED BY IB
06/12/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/27/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/27/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/27/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/11/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
05/11/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/11/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
05/11/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/11/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/04/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/04/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/05/2019
GNFR
FINAL REFUSAL E-MAILED
11/05/2019
CNFR
FINAL REFUSAL WRITTEN
11/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/15/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/15/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/15/2019
RFNT
REFUSAL PROCESSED BY IB
05/04/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/15/2019
RFRR
REFUSAL PROCESSED BY MPU
04/15/2019
MAFR
APPLICATION FILING RECEIPT MAILED
04/02/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/30/2019
CNRT
NON-FINAL ACTION WRITTEN
03/29/2019
DOCK
ASSIGNED TO EXAMINER
03/28/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/28/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/21/2019
Continuous trademark protection
Get notified about every new filing that threatens ADVITOS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.